CXCL-12 targeting was achieved through the use of RNA oligonucleotides; for example, NOX-A12 inhibits CLL-cell migration in vitro and sensitizes CLL cells to cytotoxic agents [199] (Table 2). This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.